Assignee
SYMPHOGEN AS
DK·17 granted patents·24 pending applications·387 citations·filing 2001–2022
Top patents by PatentIndex Score
41 records- 0193US11034765B2Anti-PD-1 antibodies and compositionsSYMPHOGEN AS·Filed 2016·Granted Jun 15, 2021·17 cites·20 claims
- 0293US7887805B2Recombinant anti-epidermal growth factor receptor antibody compositionsSYMPHOGEN AS·Filed 2008·Granted Feb 15, 2011·56 cites·53 claims
- 0391US10058610B2Methods for treating cancer by administering humanized pan-HER antibody compositionsSYMPHOGEN AS·Filed 2016·Granted Aug 28, 2018·9 cites·20 claims
- 0491US7850965B2Anti-orthopoxvirus recombinant polyclonal antibodySYMPHOGEN AS·Filed 2006·Granted Dec 14, 2010·36 cites·6 claims
- 0591US7749697B2Method for linking sequences of interestSYMPHOGEN AS·Filed 2004·Granted Jul 6, 2010·134 cites·29 claims
- 0690US6849259B2Polyclonal antibody composition for treating allergySYMPHOGEN AS·Filed 2001·Granted Feb 1, 2005·97 cites·25 claims
- 0786US11390676B2Anti-LAG-3 antibodies and compositionsSYMPHOGEN AS·Filed 2017·Granted Jul 19, 2022·3 cites·15 claims
- 0885US11390674B2Anti-TIM-3 antibodies and compositionsSYMPHOGEN AS·Filed 2017·Granted Jul 19, 2022·4 cites·23 claims
- 0984US7879329B2Recombinant antibodies for treatment of respiratory syncytial virus infectionsSYMPHOGEN AS·Filed 2008·Granted Feb 1, 2011·13 cites·14 claims
- 1083US7910332B2Method for manufacturing a recombinant polyclonal proteinSYMPHOGEN AS·Filed 2008·Granted Mar 22, 2011·9 cites·59 claims
- 1177US11359018B2Anti-PD-1 antibodies and compositionsSYMPHOGEN AS·Filed 2017·Granted Jun 14, 2022·2 cites·20 claims
- 1277US9527913B2Humanized pan-HER antibody compositionsSYMPHOGEN AS·Filed 2013·Granted Dec 27, 2016·4 cites·8 claims
- 1376US10221246B2Pan-HER antibody compositionSYMPHOGEN AS·Filed 2016·Granted Mar 5, 2019·2 cites·8 claims
- 1471US11939380B2Combination therapies targeting PD-1, TIM-3, and LAG-3SYMPHOGEN AS·Filed 2018·Granted Mar 26, 2024·1 cites·16 claims
- 1567US2022380470A1Combination therapies targeting pd-1, tim-3, and lag-3SYMPHOGEN AS·Filed 2022·Application pending·0 cites
- 1657US2018344846A1Humanized pan-her antibody compositionsSYMPHOGEN AS·Filed 2018·Application pending·0 cites
- 1755US2009137003A1Methods for recombinant manufacturing of anti-RSV antibodiesSYMPHOGEN AS·Filed 2008·Application pending·0 cites
- 1854US11807688B2Anti-AXL antibodies and compositionsSYMPHOGEN AS·Filed 2021·Granted Nov 7, 2023·0 cites·19 claims
- 1954US9029091B2Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell lineSYMPHOGEN AS·Filed 2012·Granted May 12, 2015·0 cites·13 claims
- 2051US2011250203A1Anti-cd5 antibodiesSYMPHOGEN AS·Filed 2009·Application pending·0 cites
- 2151US2011224094A1Method for identifying and selecting drug candidates for combinatorial drug productsSYMPHOGEN AS·Filed 2009·Application pending·0 cites
- 2251US2009093004A1Potency assaySYMPHOGEN AS·Filed 2008·Application pending·0 cites
- 2350US2016089435A1Pan-her antibody compositionSYMPHOGEN AS·Filed 2015·Application pending·0 cites
- 2450US2013023447A1Method for Cloning Cognate AntibodiesSYMPHOGEN AS·Filed 2012·Application pending·0 cites
- 2549US2010069262A1Method for Cloning Avian-Derived AntibodiesSYMPHOGEN AS·Filed 2009·Application pending·0 cites
- 2648US2021214454A1Anti-cd40 antibodies and compositionsSYMPHOGEN AS·Filed 2021·Application pending·0 cites
- 2747US2011217317A1Treatment of thrombocytopeniaSYMPHOGEN AS·Filed 2009·Application pending·0 cites
- 2847US2009186423A1Method for Characterization of a Recombinant Polyclonal ProteinSYMPHOGEN AS·Filed 2008·Application pending·0 cites
- 2946US2011117605A1Methods for Manufacturing a Polyclonal ProteinSYMPHOGEN AS·Filed 2009·Application pending·0 cites
- 3046US2010040606A1Recombinant polyclonal antibody for treatment of respiratory syncytial virus infectionsSYMPHOGEN AS·Filed 2007·Application pending·0 cites
- 3145US2013004499A1Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosaSYMPHOGEN AS·Filed 2011·Application pending·0 cites
- 3244US2011158984A1Anti-orthopoxvirus recombinant polyclonal antibodySYMPHOGEN AS·Filed 2010·Application pending·0 cites
- 3343US2013004500A1Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosaSYMPHOGEN AS·Filed 2011·Application pending·0 cites
- 3443US2013045207A1Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosaSYMPHOGEN AS·Filed 2011·Application pending·0 cites
- 3543US2011189171A1Recombinant antibodies for treatment of respiratory syncytial virus infectionsSYMPHOGEN AS·Filed 2010·Application pending·0 cites
- 3643US2013022604A1Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosaSYMPHOGEN AS·Filed 2011·Application pending·0 cites
- 3743US2013022603A1Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosaSYMPHOGEN AS·Filed 2011·Application pending·0 cites
- 3842US2005180967A1Polyclonal antibody composition for treating allergySYMPHOGEN AS·Filed 2005·Application pending·0 cites
- 3941US2020347140A1Compositions and methods for treating cancer with anti-egfr antibodiesSYMPHOGEN AS·Filed 2018·Application pending·0 cites
- 4038US2010310558A1Method for Linking Sequences of InterestSYMPHOGEN AS·Filed 2010·Application pending·0 cites
- 4131US10450376B2Anti-MET antibodies and compositionsSYMPHOGEN AS·Filed 2015·Granted Oct 22, 2019·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when SYMPHOGEN AS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →